Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Spitz

Showing results (111-120 of 179) with videos related to

Pageof 18
Sort By:
International Journal of Cancer|October 7, 1998
Chromosome 5 aberrations and genetic predisposition to lung cancerX Wu, Y Zhao, B L Kemp, et al.
The Prostate|June 9, 2001
Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: a case-control studyS S Strom, M R Spitz, Y Yamamura, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 1998
Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populationsX Wu, C I Amos, B L Kemp, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1995
Mutagen sensitivity as a biological marker of lung cancer risk in African AmericansM R Spitz, T C Hsu, X Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neckL E Wang, E M Sturgis, S A Eicher, et al.
Cancer Research|September 1, 1996
Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancerQ Wei, J Gu, L Cheng, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 29, 1998
Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinomaX Wu, J Gu, Y Patt, et al.
Clinical Genetics|August 23, 2006
E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancerJ Lin, C P Dinney, H B Grossman, et al.
Cancer Research|February 1, 1995
A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer casesX Wu, T C Hsu, J F Annegers, et al.
Carcinogenesis|May 1, 1997
Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancerX Wu, H Shi, H Jiang, et al.
Pageof 18

Showing results (111-120 of 179) with videos related to

Sort By:
Pageof 18
International Journal of Cancer|October 7, 1998
Chromosome 5 aberrations and genetic predisposition to lung cancerX Wu, Y Zhao, B L Kemp, et al.
The Prostate|June 9, 2001
Reduced expression of hMSH2 and hMLH1 and risk of prostate cancer: a case-control studyS S Strom, M R Spitz, Y Yamamura, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 1998
Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populationsX Wu, C I Amos, B L Kemp, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1995
Mutagen sensitivity as a biological marker of lung cancer risk in African AmericansM R Spitz, T C Hsu, X Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 1998
Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neckL E Wang, E M Sturgis, S A Eicher, et al.
Cancer Research|September 1, 1996
Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancerQ Wei, J Gu, L Cheng, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 29, 1998
Mutagen sensitivity as a susceptibility marker for human hepatocellular carcinomaX Wu, J Gu, Y Patt, et al.
Clinical Genetics|August 23, 2006
E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancerJ Lin, C P Dinney, H B Grossman, et al.
Cancer Research|February 1, 1995
A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer casesX Wu, T C Hsu, J F Annegers, et al.
Carcinogenesis|May 1, 1997
Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancerX Wu, H Shi, H Jiang, et al.
Pageof 18